Some IBD Treatments in Pregnancy Had No Effect on Kids’ Infection Risk
Exposure to immunosuppressive monotherapies in utero did not increase serious infection risks in young children born to mothers with inflammatory bowel disease (IBD), but the same could not be said for exposures to combination therapies, a French population-based study found. Children up to 1 year of age who were exposed to tumor necrosis factor (TNF) […]